What is the current Biohaven Pharmaceutical Holding Company market capitalization?
The current market capitalization of Biohaven Pharmaceutical Holding Company is 2.51 B USD.
Biohaven Pharmaceutical Holding Company Market capitalization 2024
Biohaven Pharmaceutical Holding Company Market capitalization
2.51 B USD
Ticker
BHVN
ISIN
VGG111961055
WKN
A2DQ7W
In 2024, Biohaven Pharmaceutical Holding Company's market cap stood at 2.51 B USD, a 37.53% increase from the 1.83 B USD market cap in the previous year.
The Biohaven Pharmaceutical Holding Company Market capitalization history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) | NET INCOME (undefined USD) |
|---|---|---|---|
| 2029e | 1.49 | 24,89 | 301.69 |
| 2028e | 0.9 | 41,13 | -21.61 |
| 2027e | 0.45 | 83,06 | -249.45 |
| 2026e | 0.16 | 230,64 | -498.91 |
| 2025e | 0.01 | 3247,90 | -600.38 |
| 2024e | 0.01 | 3632,89 | -659.27 |
| 2023 | - | - | -408.17 |
| 2022 | - | - | -570.28 |
| 2021 | - | - | -213.8 |
| 2020 | - | - | -118.67 |
| 2019 | - | - | -528.8 |
| 2018 | - | - | -240.92 |
| 2017 | - | - | -139.2 |
| 2016 | - | - | -63.68 |
| 2015 | - | - | -10.06 |
| 2014 | - | - | -1.46 |
Biohaven Pharmaceutical Holding Company Aktienanalyse
What does Biohaven Pharmaceutical Holding Company do?
Biohaven Pharmaceutical is a biopharmaceutical company focused on developing innovative therapies for neurological disorders. It was founded in 2013 and is headquartered in New Haven, Connecticut. The company's business model is based on discovering and developing novel medications for conditions such as migraine, spinal muscular atrophy, Alzheimer's, and other neurological disorders. Biohaven invests in research and development to create therapies that can enhance patients' lives. It has divisions dedicated to developing treatments for migraine, neurodegeneration, and spinal muscular atrophy. Biohaven's first product, Rimegepant, is a migraine medication that inhibits the CGRP receptor. It has been approved in the US for migraine treatment. Troriluzol, another migraine medication, is still in clinical development. Biohaven is also active in the fields of Alzheimer's and ALS, with medications like BHV-0223 and BHV-4157 in development. The company aims to develop innovative medications that can improve and restore patient health. It collaborates with other companies and research institutions to maximize its research potential and bring innovative therapies to market faster. Overall, Biohaven Pharmaceutical is a leading biopharmaceutical company dedicated to developing innovative therapies for neurological disorders, with a strong pipeline of medications and a committed research and development department working towards improving global patient healthcare. Biohaven Pharmaceutical Holding Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Biohaven Pharmaceutical Holding Company's Market Capitalization
Biohaven Pharmaceutical Holding Company's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Biohaven Pharmaceutical Holding Company's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Biohaven Pharmaceutical Holding Company's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Biohaven Pharmaceutical Holding Company’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Biohaven Pharmaceutical Holding Company Stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Biohaven Pharmaceutical Holding Company.
How has the market capitalization of Biohaven Pharmaceutical Holding Company developed in recent years?
The market capitalization of Biohaven Pharmaceutical Holding Company has increased/decreased by 37.53% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Biohaven Pharmaceutical Holding Company?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Biohaven Pharmaceutical Holding Company?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Biohaven Pharmaceutical Holding Company have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Biohaven Pharmaceutical Holding Company pay?
Over the past 12 months, Biohaven Pharmaceutical Holding Company paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biohaven Pharmaceutical Holding Company is expected to pay a dividend of 0 USD.
What is the dividend yield of Biohaven Pharmaceutical Holding Company?
The current dividend yield of Biohaven Pharmaceutical Holding Company is .
When does Biohaven Pharmaceutical Holding Company pay dividends?
Biohaven Pharmaceutical Holding Company pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biohaven Pharmaceutical Holding Company?
Biohaven Pharmaceutical Holding Company paid dividends every year for the past 0 years.
What is the dividend of Biohaven Pharmaceutical Holding Company?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biohaven Pharmaceutical Holding Company located?
Biohaven Pharmaceutical Holding Company is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biohaven Pharmaceutical Holding Company kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biohaven Pharmaceutical Holding Company from 7/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/2/2024.
When did Biohaven Pharmaceutical Holding Company pay the last dividend?
The last dividend was paid out on 7/2/2024.
What was the dividend of Biohaven Pharmaceutical Holding Company in the year 2023?
In the year 2023, Biohaven Pharmaceutical Holding Company distributed 0 USD as dividends.
In which currency does Biohaven Pharmaceutical Holding Company pay out the dividend?
The dividends of Biohaven Pharmaceutical Holding Company are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biohaven Pharmaceutical Holding Company
Our stock analysis for Biohaven Pharmaceutical Holding Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biohaven Pharmaceutical Holding Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Biohaven Pharmaceutical Holding Company Revenue
- Biohaven Pharmaceutical Holding Company Net Income
- Biohaven Pharmaceutical Holding Company P/E
- Biohaven Pharmaceutical Holding Company P/S
- Biohaven Pharmaceutical Holding Company EBIT
- Biohaven Pharmaceutical Holding Company Dividend
- Biohaven Pharmaceutical Holding Company Stocks
- Biohaven Pharmaceutical Holding Company Market capitalization
- Biohaven Pharmaceutical Holding Company Debt
- Biohaven Pharmaceutical Holding Company Liabilities
- Biohaven Pharmaceutical Holding Company Equity
- Biohaven Pharmaceutical Holding Company AAQS
- Biohaven Pharmaceutical Holding Company Employees
- Biohaven Pharmaceutical Holding Company ROE
- Biohaven Pharmaceutical Holding Company ROA
- Biohaven Pharmaceutical Holding Company ROCE
